search
drug regulators
Trends
- 1Americans Set to Lose Access to Canadian Prescription Drugs●Americans Are About to Lose Access to Prescriptions from Canada
US Customs is moving to block Americans from importing prescription drugs from Canada, a long-used workaround for high US medication prices, according to the Wall Street Journal. Many patients, particularly retirees and those without adequate insurance, rely on Canadian pharmacies for cheaper drugs like insulin, and the change could raise their costs sharply. Commenters are debating drug pricing policy and whether US regulators will address domestic prices alongside the import crackdown.
- 2Platform Trials Are Rewriting the Rules of Evidence●Platform Trials Are Rewriting the Rules of Evidence. Regulators Haven’t Caught Up.
Platform trials, which test multiple treatments simultaneously against a shared control group, are increasingly used in medicine and are changing how clinical evidence is generated. Critics and commentators argue that drug regulators have not adapted their evaluation frameworks to this faster, more flexible trial design, raising questions about how such evidence should be assessed and approved.